FrostPharma AB (FrostPharma) has entered agreement with Farco-Pharma to be exclusive distributor of innovative Farco-products in the Nordic countries.
FrostPharma will employ its extensive commercial expertise to distribute Instillagel®. Instillagel® is a lubricant with local anaesthetic and disinfecting properties.
The agreement includes additional product that will be brought to market in the near-term future.
“This agreement is a valuable strategic fit to our current portfolio”, says Clas Lindbergson, Head of Business Development at FrostPharma. Cecilia Bröms-Thell, CEO, adds: “We are excited about the collaboration with Farco, market leader for medical lubrication in Germany. This means we will bring valuable products to the Nordic market.”
